In this study, three of the 33 DCM patients volunteered to undergo flow cytometry assessment of plasma interleukin-2 (IL2), plasma interleukin-4 (IL4), and tumor necrosis factor-α (TNF-α). The gene discussed is TNF; the disease is familial dilated cardiomyopathy.